OPHENOIL LONGEVITY FORMULA

Supporting Longevity by Combating Inflammation: The Role of OPHENOIL Longevity Formula

The Core Threat: Chronic Inflammation and Aging

Modern medical science highlights that while acute inflammation serves as the body’s primary immune defense against tissue damage, viruses, and bacteria, a prolonged immune response can transform into harmful chronic inflammation. This systemic shift is an established driver of aging and a variety of severe modern illnesses, including cardiovascular diseases, neurodegenerative disorders like Alzheimer's, metabolic disorders, and certain cancers. Mitigating this continuous inflammatory state is vital for extending a healthy human lifespan. 

The Solution: OPHENOIL Longevity Formula (Powered by OLIGEN) 

The market target for advanced wellness focuses on food supplements capable of delivering highly concentrated, bioactive compounds with proven potency against these inflammation-related conditions . 


OPHENOIL Longevity Formula, engineered through scientific collaboration with Goldmed Suisse S.A., addresses this exact need:

  • High-Concentration Bioactive Compounds: Formulated to supply a potent dose of natural polyphenols—specifically featuring an exceptionally high concentration of Oleocanthal and 10-hydroxyoleocanthal.
  • Natural Anti-Inflammatory & Antioxidant Action: Oleocanthal acts as a premier natural anti-inflammatory agent.It mirrors the pathways of cellular protection by directly reducing systemic oxidative stress and the chronic inflammatory markers that trigger cellular degeneration.
  • Targeted Longevity Support: By protecting the body's microcirculation and combating the root causes of systemic wear and tear, this formulation actively helps shield the body against age-related decline, metabolic dysregulation, and neurodegeneration. 

Through the concentrated delivery of OLIGEN's specialized phenolic profile, OPHENOIL shifts nutrition from simple sustenance to strategic cellular defense, serving as a powerful preventative tool to support overall longevity.

Image

IMAGE courtesy of: Liviu Aron, Joseph Zullo, Bruce A. Yankner, The adaptive aging brain, Current Opinion in Neurobiology, Volume 72, N2022, https://doi.org/10.1016/j.conb.2021.09.009. (https://www.sciencedirect.com/science/article/pii/S0959438821001094) Abstract: The aging brain is shaped by many structural and functional alterations. Recent cross-disciplinary efforts have uncovered powerful and integrated adaptive mechanisms that promote brain health and prevent functional decline during aging. Here, we review some of the most robust adaptive mechanisms and how they can be engaged to protect, and restore the aging brain.

Several benefits have been attributed to the consumption of olive oil, such as antioxidant properties, prevention in cardiovascular disease, chemoprevention, lower incidence of neurological disorders and neurodegeneration and protection towards inflammatory bowel diseases.

Most of these properties are due to the phenolic compounds present in extra virgin olive oil, such as hydroxytyrosol, oleuropein and oleocanthal.

NOTE FOR THE VIEWER : Accordingly, with EFSA definition the Food supplements are concentrated sources of nutrients (i.e. mineral and vitamins) or other substances with a nutritional or physiological effect that are marketed in “dose ” form (e.g. pills, tablets, capsules, liquids in measured doses). A wide range of nutrients and other ingredients might be present in food supplements, including, but not limited to, vitamins, minerals, amino acids, essential fatty acids, fibre and various plants and herbal extracts. https://www.efsa.europa.eu/en/topics/topic/food-supplements#

THE R&D HERITAGE & CLINICAL Study

Prof.ssa Annalisa Romani and dott.ssa Elisabetta Ciccone at the University of Florence R&D Lab Center - 2020

Image
Image

Peer‑Reviewed Foundations:

  • Nutrients (2019): Validated the profound antioxidant, anti‑inflammatory, and chemopreventive properties of EVOO polyphenols on cellular health.
  • Molecules (2020): Published the groundbreaking in‑vivo pilot study results from our Tor Vergata trials. dui.
Image
Image

The Policlinico fo Tor Vergata Campus Biomedico Team with the University of Florence ( Prof.Annalisa Romani the third from right) and OphenOil Business Development Manager ( Dr. Elisabetta Ciccone, first from left).

Image